Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950008-98-000170
Filing Date
1998-04-06
Accepted
1998-04-06 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A SC 13G/A 12447
  Complete submission text file 0000950008-98-000170.txt   14476
Mailing Address 3174 PORTER DRIVE 3174 PORTER DRIVE PALO ALTO CA 94304
Business Address 3174 PORTER DR PALO ALTO CA 94304 6508550555
INCYTE PHARMACEUTICALS INC (Filed by) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 205 PERRY PARKWAY SUITE 3 HAITHERSBURG MD 20877
Business Address 205 PERRY PARKWAY SUITE 3 GAITHERSBURG MD 20877 3012081888
ONCORMED INC (Subject) CIK: 0000922821 (see all company filings)

EIN.: 521842781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44699 | Film No.: 98587732
SIC: 8071 Services-Medical Laboratories